The Center for Veterinary Medicine’s Executive Board is pleased to report to the nation that FY2012 was a remarkable year. The past year at CVM has been a time of extraordinary challenge and change—a time during which we enhanced our focus on food and feed safety, approved new animal drugs to alleviate pain and illness, and transformed how we communicate globally and engage with the public in real time. In many ways, we have met the national challenge of tighter budgets by approaching our work virtually with improved technology.
We share the honor of working with many dedicated scientists and veterinarians as we approach human and animal health challenges every day. The bond between humans and animals is evident at CVM in our personal lives, and in our pursuit of better approaches to solving health issues such as antimicrobial resistance and drug residues. Because our health and the health of animals are so intrinsically connected, we cannot be complacent in our pursuit of scientific solutions to disease or safety.
The times in which we live demand that we continually re-dedicate ourselves to learning more about the way we conduct our work and share our results with the public. Continually striving to improve the public health, the combined diligence of CVM scientists, veterinarians, and managers leads to a safer food supply from farm to table.
We know that technological change will continue to profoundly improve our ability to mitigate disease and improve animal and human health. We continue to harness the power of technology to expand our capabilities in preventing food borne illness and tracking the cause when it does occur. CVM has built a strong research foundation by combining our cumulative knowledge, our institutional history, and our constantly developing technological expertise.
As challenge and change mounts, we continue to exert our positive influence on the shared destiny of animals and humans. We are driven to think and act in new ways—to develop opportunities to share our knowledge and learn from our international associates. In a world made up of so many Tweeting impressions, it is essential that we maintain our dedication to our mission at all times and hold firmly to the scientific and human values that will guide us—and the people and animals we serve—into a safer and healthier future.
CVM Executive Board
(Pictured above left to right)
- Bernadette Dunham, D.V.M., Ph.D., Center Director
- Catherine Beck, Associate Director for Policy and Communications
- Eric Dubbin, D.V.M., Management Consultant
- Tracey Forfa, J.D., Deputy Director
- David White, Ph.D., Director of the Office of Research
- Roxanne Schweitzer, Associate Director for Management
- Steven Vaughn, D.V.M., Director of the Office of New Animal Drug Evaluation
- William Flynn, D.V.M., M.S., Deputy Director for Science Policy
- Daniel McChesney, Ph.D., Director of the Office of Surveillance and Compliance